Physician_Profile_ID,Category,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Category,Record_ID
333330,GNRL,"Bayer HealthCare Pharmaceuticals Inc.",NJ,100000005467,1100.00,11/20/2013,GNRL,31064835
333330,GNRL,"Incyte Corporation",DE,100000000263,250.00,11/14/2015,GNRL,298492348
333330,GNRL,"Seattle Genetics, Inc.",WA,100000000279,135.16,08/23/2015,GNRL,341821286
333330,GNRL,"Celgene Corporation",NJ,100000000343,126.52,12/10/2015,GNRL,328494232
333330,GNRL,"Millennium Pharmaceuticals, Inc.",MA,100000000080,115.09,05/04/2015,GNRL,335417038
333330,GNRL,"Onyx Pharmaceuticals, Inc., an Amgen subsidiary",CA,100000000276,113.68,10/03/2013,GNRL,102469220
333330,GNRL,"Lilly USA, LLC",IN,100000000066,113.00,05/18/2015,GNRL,268171054
333330,GNRL,"ASD Specialty Healthcare, Inc.",TX,100000010920,112.85,10/30/2014,GNRL,195521380
333330,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,105.85,11/10/2015,GNRL,290184358
333330,GNRL,"Onyx Pharmaceuticals, Inc., an Amgen subsidiary",CA,100000000276,103.59,12/04/2013,GNRL,102468758
333330,GNRL,"Genentech USA, Inc.",CA,100000000226,100.38,11/02/2015,GNRL,318132460
333330,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,99.95,01/14/2014,GNRL,188473226
333330,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,99.61,10/14/2015,GNRL,290184360
333330,GNRL,"Celgene Corporation",NJ,100000000343,98.12,05/01/2014,GNRL,189919892
333330,GNRL,"Onyx Pharmaceuticals, Inc., an Amgen subsidiary",CA,100000000276,97.99,10/29/2014,GNRL,227553056
333330,GNRL,"Onyx Pharmaceuticals, Inc., an Amgen subsidiary",CA,100000000276,97.62,04/23/2014,GNRL,227553054
333330,GNRL,"Celgene Corporation",NJ,100000000343,97.46,04/15/2015,GNRL,328257498
333330,GNRL,"Amgen Inc.",CA,100000000203,97.12,04/09/2015,GNRL,297930276
333330,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,96.06,06/16/2015,GNRL,290184362
333330,GNRL,"Celgene Corporation",NJ,100000000343,95.44,10/09/2013,GNRL,101789752
333330,GNRL,"Amgen Inc.",CA,100000000203,94.85,04/01/2015,GNRL,297930274
333330,GNRL,"Celgene Corporation",NJ,100000000343,94.27,08/18/2014,GNRL,189922178
333330,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,91.81,03/05/2014,GNRL,196061768
333330,GNRL,"Onyx Pharmaceuticals, Inc., an Amgen subsidiary",CA,100000000276,91.71,01/22/2014,GNRL,227553052
333330,GNRL,"Seattle Genetics, Inc.",WA,100000000279,89.16,08/20/2013,GNRL,25422069
333330,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,88.99,05/06/2015,GNRL,275822036
333330,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,88.61,09/09/2015,GNRL,319050106
333330,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,88.45,09/09/2015,GNRL,319179745
333330,GNRL,"Celgene Corporation",NJ,100000000343,88.36,06/18/2015,GNRL,328237360
333330,GNRL,"Cardinal Health 108, LLC",OH,100000010445,87.47,09/23/2014,GNRL,145691450
333330,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,86.94,06/24/2015,GNRL,275822042
333330,GNRL,"Cardinal Health 108, LLC",OH,100000010445,86.60,04/15/2014,GNRL,145688332
333330,GNRL,"Cardinal Health 108, LLC",OH,100000010445,86.20,09/03/2014,GNRL,145691460
333330,GNRL,"Amgen Inc.",CA,100000000203,86.03,05/19/2015,GNRL,297930278
333330,GNRL,"McKesson Specialty Care Distribution Corp.",CA,100000010520,85.00,06/10/2014,GNRL,211751948
333330,GNRL,"Celgene Corporation",NJ,100000000343,84.85,12/10/2014,GNRL,189943754
333330,GNRL,"Amgen Inc.",CA,100000000203,84.57,09/04/2014,GNRL,138094040
333330,GNRL,"Bayer HealthCare Pharmaceuticals Inc.",NJ,100000005467,83.59,10/29/2013,GNRL,31072512
333330,GNRL,"Onyx Pharmaceuticals, Inc., an Amgen subsidiary",CA,100000000276,80.89,11/10/2014,GNRL,227553058
333330,GNRL,"Cardinal Health 108, LLC",OH,100000010445,71.07,08/21/2015,GNRL,292915666
333330,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,69.89,11/17/2015,GNRL,331049001
333330,GNRL,"Cardinal Health 108, LLC",OH,100000010445,65.61,01/13/2015,GNRL,292915214
333330,GNRL,"Onyx Pharmaceuticals, Inc., an Amgen subsidiary",CA,100000000276,65.31,12/19/2013,GNRL,102468804
333330,GNRL,"Cardinal Health 108, LLC",OH,100000010445,65.21,10/21/2014,GNRL,145691636
333330,GNRL,"Cardinal Health 108, LLC",OH,100000010445,64.75,11/04/2014,GNRL,145691792
333330,GNRL,"Astellas Pharma US Inc",IL,100000000137,54.95,09/24/2013,GNRL,111740802
333330,GNRL,"Cardinal Health 108, LLC",OH,100000010445,54.75,09/16/2015,GNRL,292915734
333330,GNRL,"Gilead Sciences Inc",CA,100000000108,52.14,12/01/2014,GNRL,167287514
333330,GNRL,"ASD Specialty Healthcare, Inc.",TX,100000010920,51.30,08/26/2013,GNRL,103132486
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,50.96,11/06/2013,GNRL,24070442
333330,GNRL,"Cardinal Health 108, LLC",OH,100000010445,50.01,09/14/2015,GNRL,292915708
333330,GNRL,"Celgene Corporation",NJ,100000000343,40.86,05/12/2015,GNRL,328296466
333330,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,21.35,01/15/2015,GNRL,293660230
333330,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,20.89,12/30/2015,GNRL,290184208
333330,GNRL,"Genentech USA, Inc.",CA,100000000226,19.43,11/16/2015,GNRL,318185046
333330,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,18.28,07/28/2015,GNRL,263311904
333330,GNRL,"Genentech USA, Inc.",CA,100000000226,18.20,05/06/2014,GNRL,208257426
333330,GNRL,"Genentech USA, Inc.",CA,100000000226,18.06,02/19/2014,GNRL,208128136
333330,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,17.78,10/14/2015,GNRL,290184210
333330,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,17.69,05/05/2015,GNRL,331671565
333330,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,17.33,10/28/2015,GNRL,319456166
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,17.27,11/05/2013,GNRL,24070445
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,17.15,09/18/2013,GNRL,24070443
333330,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,16.65,09/01/2015,GNRL,331907483
333330,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,16.60,04/01/2015,GNRL,331588227
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,16.57,11/18/2014,GNRL,152597056
333330,GNRL,"Eisai Inc.",NJ,100000000136,16.55,01/08/2014,GNRL,184747880
333330,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,16.47,03/31/2015,GNRL,263311892
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,16.40,08/12/2014,GNRL,152597062
333330,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,16.36,09/10/2015,GNRL,263311908
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,16.23,10/07/2014,GNRL,152597046
333330,GNRL,"Alexion Pharmaceuticals, Inc.",CT,100000005462,16.08,06/09/2015,GNRL,338109192
333330,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,15.95,10/09/2013,GNRL,14269817
333330,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,15.82,01/28/2014,GNRL,173426584
333330,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,15.52,10/12/2015,GNRL,263311870
333330,GNRL,"Medivation Inc.",CA,100000010858,14.99,10/08/2014,GNRL,221247752
333330,GNRL,"Valeant Pharmaceuticals North America LLC",NJ,100000010935,14.91,05/04/2015,GNRL,295406566
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,14.84,08/28/2013,GNRL,24070444
333330,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,14.83,01/20/2015,GNRL,319333674
333330,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,14.81,01/16/2015,GNRL,263311882
333330,GNRL,"Astellas Pharma US Inc",IL,100000000137,14.80,09/28/2015,GNRL,294926156
333330,GNRL,"Genentech USA, Inc.",CA,100000000226,14.50,09/23/2015,GNRL,317763154
333330,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,14.43,04/29/2015,GNRL,263311894
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,14.34,05/28/2014,GNRL,152597044
333330,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,14.26,06/11/2014,GNRL,196061764
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,14.24,01/29/2014,GNRL,152597028
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,14.24,09/30/2014,GNRL,152597038
333330,GNRL,"Medivation Inc.",CA,100000010858,14.16,10/21/2015,GNRL,339289502
333330,GNRL,"Janssen Biotech, Inc.",PA,100000000329,14.13,11/30/2015,GNRL,270320794
333330,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,14.10,02/24/2015,GNRL,263311884
333330,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,14.08,04/07/2015,GNRL,263311890
333330,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,14.06,08/18/2015,GNRL,263311906
333330,GNRL,"Incyte Corporation",DE,100000000263,14.06,03/24/2015,GNRL,298492346
333330,GNRL,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,13.98,08/19/2015,GNRL,333367244
333330,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,13.89,03/04/2014,GNRL,202773368
333330,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,13.87,11/10/2015,GNRL,263311880
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,13.86,06/04/2014,GNRL,152597026
333330,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.71,01/07/2014,GNRL,196061766
333330,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,13.66,07/14/2015,GNRL,318669795
333330,GNRL,"Astellas Pharma US Inc",IL,100000000137,13.62,09/04/2013,GNRL,111744104
333330,GNRL,"LILLY USA, LLC",IN,100000000066,13.52,12/03/2013,GNRL,4720530
333330,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,13.47,12/22/2015,GNRL,275822030
333330,GNRL,"Pfizer Inc.",NY,100000000286,13.44,10/16/2015,GNRL,323462238
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,13.40,03/05/2014,GNRL,152597058
333330,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,13.23,02/18/2015,GNRL,331529729
333330,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,13.22,01/13/2015,GNRL,275822026
333330,GNRL,"Celgene Corporation",NJ,100000000343,13.22,09/08/2015,GNRL,328426002
333330,GNRL,"Genentech USA, Inc.",CA,100000000226,13.16,02/18/2014,GNRL,208128134
333330,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,13.04,10/06/2015,GNRL,263311868
333330,GNRL,"Luitpold Pharmaceuticals Inc",NY,100000010540,13.03,10/22/2013,GNRL,29499414
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,12.96,10/07/2013,GNRL,24070447
333330,GNRL,"Celgene Corporation",NJ,100000000343,12.88,04/01/2014,GNRL,189955448
333330,GNRL,"Amgen Inc.",CA,100000000203,12.67,11/26/2013,GNRL,8991002
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,12.59,08/06/2014,GNRL,152597054
333330,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,12.45,09/22/2015,GNRL,263311910
333330,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,12.42,02/11/2015,GNRL,293660226
333330,GNRL,"Medivation Inc.",CA,100000010858,12.39,07/15/2015,GNRL,339289500
333330,GNRL,"Astellas Pharma US Inc",IL,100000000137,12.32,11/11/2014,GNRL,168527098
333330,GNRL,"Spectrum Pharmaceuticals Inc.",NV,100000011115,12.20,07/22/2015,GNRL,340701848
333330,GNRL,"Amgen Inc.",CA,100000000203,12.19,04/22/2014,GNRL,138094036
333330,GNRL,"Genentech USA, Inc.",CA,100000000226,12.18,11/06/2013,GNRL,29805800
333330,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,12.12,01/14/2014,GNRL,188504966
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,12.10,08/06/2013,GNRL,24070449
333330,GNRL,"Amgen Inc.",CA,100000000203,12.10,03/25/2014,GNRL,138094034
333330,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,12.09,10/15/2013,GNRL,171848450
333330,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,11.99,05/06/2015,GNRL,275822038
333330,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,11.87,12/02/2015,GNRL,275822028
333330,GNRL,"Ipsen Biopharmaceuticals, Inc",NJ,100000000123,11.86,09/16/2015,GNRL,341511336
333330,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,11.81,06/16/2015,GNRL,275822044
333330,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,11.72,09/14/2015,GNRL,263311912
333330,GNRL,"Genentech USA, Inc.",CA,100000000226,11.66,08/14/2013,GNRL,29805801
333330,GNRL,"Onyx Pharmaceuticals, Inc., an Amgen subsidiary",CA,100000000276,11.64,12/04/2013,GNRL,102469258
333330,GNRL,"Janssen Diagnostics, LLC",NJ,100000005596,11.58,07/23/2014,GNRL,155725844
333330,GNRL,"Pfizer Inc.",NY,100000000286,11.50,06/24/2015,GNRL,322764274
333330,GNRL,"Pfizer Inc.",NY,100000000286,11.46,02/10/2015,GNRL,323713164
333330,GNRL,"Eisai Inc.",NJ,100000000136,11.41,11/24/2014,GNRL,184747878
333330,GNRL,"Astellas Pharma US Inc",IL,100000000137,11.08,06/30/2015,GNRL,294770974
333330,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,11.03,06/17/2015,GNRL,263311902
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,10.99,02/26/2014,GNRL,152597042
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,10.88,06/25/2014,GNRL,152597036
333330,GNRL,"Amgen Inc.",CA,100000000203,10.63,09/03/2014,GNRL,138094038
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,10.62,11/05/2014,GNRL,152597040
333330,GNRL,"Celgene Corporation",NJ,100000000343,10.52,10/14/2014,GNRL,189842710
333330,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,10.52,10/07/2015,GNRL,263311872
333330,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,10.45,09/16/2014,GNRL,198798846
333330,GNRL,"Amgen Inc.",CA,100000000203,10.38,06/03/2015,GNRL,297863984
333330,GNRL,"Medivation Inc.",CA,100000010858,10.34,04/15/2015,GNRL,339289496
333330,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,10.28,10/22/2014,GNRL,202766026
333330,GNRL,"Lilly USA, LLC",IN,100000000066,10.19,05/21/2015,GNRL,268171052
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,9.83,04/15/2014,GNRL,152597034
333330,GNRL,"Seattle Genetics, Inc.",WA,100000000279,9.80,08/07/2013,GNRL,25422068
333330,GNRL,"Seattle Genetics, Inc.",WA,100000000279,9.76,11/19/2013,GNRL,25422070
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,9.73,09/09/2014,GNRL,152597064
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,9.67,06/23/2014,GNRL,152597050
333330,GNRL,"Celgene Corporation",NJ,100000000343,9.61,02/19/2015,GNRL,328300026
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,9.11,10/28/2014,GNRL,152597066
333330,GNRL,"Onyx Pharmaceuticals, Inc., an Amgen subsidiary",CA,100000000276,8.80,10/03/2013,GNRL,102468206
333330,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,8.74,03/11/2015,GNRL,263311888
333330,GNRL,"Seattle Genetics, Inc.",WA,100000000279,8.74,11/11/2015,GNRL,341821292
333330,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,8.60,05/22/2015,GNRL,263311898
333330,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,8.56,11/18/2015,GNRL,263311876
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,8.53,05/21/2014,GNRL,152597060
333330,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,8.20,06/10/2015,GNRL,263311896
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,8.13,10/23/2013,GNRL,24070439
333330,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,8.06,10/29/2015,GNRL,263311874
333330,GNRL,"Celgene Corporation",NJ,100000000343,7.95,10/29/2014,GNRL,189866844
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,7.68,02/04/2014,GNRL,152597030
333330,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,7.64,12/15/2015,GNRL,263311878
333330,GNRL,"Seattle Genetics, Inc.",WA,100000000279,7.62,07/07/2015,GNRL,341821282
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,7.55,04/15/2014,GNRL,152597032
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,7.50,04/30/2014,GNRL,152597020
333330,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,7.36,05/19/2015,GNRL,263311900
333330,GNRL,"Seattle Genetics, Inc.",WA,100000000279,7.32,02/19/2015,GNRL,341821276
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,7.18,11/27/2013,GNRL,24070448
333330,GNRL,"Luitpold Pharmaceuticals Inc",NY,100000010540,7.08,05/20/2014,GNRL,172031688
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,6.74,03/26/2014,GNRL,152597024
333330,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,6.68,07/20/2015,GNRL,275822048
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,6.49,10/23/2013,GNRL,24070441
333330,GNRL,"Lilly USA, LLC",IN,100000000066,5.88,03/04/2015,GNRL,268171046
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,5.83,10/30/2014,GNRL,152597048
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,5.36,09/10/2013,GNRL,24070446
333330,GNRL,"Celgene Corporation",NJ,100000000343,4.89,01/12/2015,GNRL,328307098
333330,GNRL,"Lilly USA, LLC",IN,100000000066,3.19,03/04/2015,GNRL,268171048
333330,GNRL,"Amgen Inc.",CA,100000000203,1.93,02/13/2014,GNRL,138094030
333330,GNRL,"Luitpold Pharmaceuticals Inc",NY,100000010540,1.88,05/20/2014,GNRL,172031686
333330,GNRL,"LILLY USA, LLC",IN,100000000066,1.81,12/03/2013,GNRL,4723788
333330,GNRL,"Lilly USA, LLC",IN,100000000066,1.77,03/04/2015,GNRL,268171050
333330,GNRL,"Onyx Pharmaceuticals, Inc., an Amgen subsidiary",CA,100000000276,1.66,12/04/2013,GNRL,102470038
333330,GNRL,"Luitpold Pharmaceuticals Inc",NY,100000010540,1.38,10/22/2013,GNRL,29499416
333330,GNRL,"Amgen Inc.",CA,100000000203,1.22,02/27/2014,GNRL,138094032
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,1.04,08/06/2014,GNRL,152597052
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,0.99,04/30/2014,GNRL,152597022
333330,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,0.96,10/23/2013,GNRL,24070440
333330,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.83,05/06/2015,GNRL,275822040
333330,GNRL,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,0.82,03/11/2015,GNRL,263311886
333330,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.80,07/23/2015,GNRL,275822050
333330,GNRL,"Luitpold Pharmaceuticals Inc",NY,100000010540,0.75,10/22/2013,GNRL,29499406
333330,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.66,06/16/2015,GNRL,275822046
333330,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.47,12/22/2015,GNRL,275822032
333330,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,0.37,01/13/2015,GNRL,275822034
